Process for generating therapeutic compositions of engineered cells
The present disclosure provides methods for genetically engineering T cells, such as CD4+ T cells, for use in cell therapy. In some aspects, the provided methods include one or more steps for incubating the cells under stimulating conditions, introducing a recombinant polypeptide to the cells throug...
Saved in:
Main Authors | , , , , , , , , , |
---|---|
Format | Patent |
Language | English |
Published |
07.05.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!